BioStem Technologies's total assets for Q3 2024 were $104.20M, an increase of 15.19% from the previous quarter. BSEM total liabilities were $81.37M for the fiscal quarter, a 12.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.